|
|
ChromosOmics - Database
|
-
CHROMOSOME 21 -
-
unclear if maternal or paternal UPD -
|
|
|
mat or pat
UPD-cases without clinical findings + normal karyotype
|
case no.
|
gender
|
age at diagnosis
|
tudied
material
|
GTG-banding result
|
clinical symptoms
|
reference
|
21-
OU-N/
1-1
|
n.a.
|
adult
|
PBL
|
n.a.
|
most likely
normal, maybe schizophrenia
|
{912} 1
case
|
mosaic cases
case no.
|
gender
|
age at
diagnosis
|
studied
material
|
GTG-banding
result
|
clinical
symptoms
|
reference
|
21-
OU-N/
mos/
1-1 |
- |
- |
- |
- |
- |
- |
|
mat or pat UPD-cases without
clinical findings + balanced karyotype |
case no.
|
gender
|
age at diagnosis
|
studied
material
|
GTG-banding result
|
clinical symptoms
|
reference
|
21-
OU-bal/
1-1
|
- |
- |
- |
- |
- |
- |
|
mat or pat UPD-cases without
clinical findings + sSMC
|
case no.
|
case no. in
sSMC database
|
gender/
age at diagnosis
|
studied
material
|
GTG-banding
result
|
final FISH
result of the sSMC
|
FISH
methods
|
clinical
symptoms
|
reference
|
21-
OU-sSMC/
1-1
|
- |
- |
- |
- |
- |
- |
- |
- |
|
segmental
mat or pat UPD-cases without clinical findings
|
case no.
|
gender
|
age at diagnosis
|
studied
material
|
GTG-banding result
|
clinical symptoms
|
reference
|
21-
OU-seg/
/
1-1
|
-
|
-
|
-
|
- |
-
|
- |
mosaic cases
case no.
|
gender
|
age at
diagnosis
|
studied
material
|
GTG-banding
result
|
clinical
symptoms
|
reference
|
21-
OU-seg/
/
mos/
1-1
|
-
|
-
|
-
|
- |
-
|
- |
|
mat or pat UPD-cases without clinical findings +
other imbalances |
case no.
|
gender
|
age at diagnosis
|
studied
material
|
GTG-banding result
|
clinical symptoms
|
reference
|
21-
OU-seg/
/
1-1
|
-
|
-
|
-
|
- |
-
|
- |
mosaic cases
case no.
|
gender
|
age at
diagnosis
|
studied
material
|
GTG-banding
result
|
clinical
symptoms
|
reference
|
21-
OU-seg/
q22.11/
mos/
1-1
|
n.a.
|
adult
|
PBL
|
n.a.; acc. to
array no imbalance in PBL
---
21q22.11 to
21qter (in 20% of PBL)
|
normal adult
with bladder cancer
|
{545} case
138
|
|
mat
or pat UPD-cases with or unclear clinical
correlation + normal karyotype |
case no.
|
gender
|
age at diagnosis
|
studied
material
|
GTG-banding result
|
clinical symptoms
|
reference
|
21-
WU-N/
1-1
|
- |
- |
- |
- |
- |
- |
mosaic cases
case no.
|
gender
|
age at
diagnosis
|
studied
material
|
GTG-banding
result
|
clinical
symptoms
|
reference
|
21-
WU-N/
mos/
1-1
|
- |
- |
- |
- |
- |
- |
|
mat
or pat UPD-cases with or unclear clinical
correlation+ balanced karyotype
|
case no.
|
gender
|
age at diagnosis
|
studied
material
|
GTG-banding result
|
clinical symptoms
|
reference
|
21-
WU-bal/
1-1 |
-
|
-
|
-
|
-
|
-
|
-
|
|
mat
or pat UPD-cases with or unclear clinical findings +
sSMC
|
case no.
|
case no. in
sSMC database
|
gender/
age at diagnosis
|
studied
material
|
GTG-banding
result
|
final FISH
result of the sSMC
|
FISH
methods
|
clinical
symptoms
|
reference
|
21-
WU-sSMC/
1-1
|
- |
- |
- |
- |
- |
- |
- |
- |
|
segmental
mat or pat UPD-cases with or unclear clinical
correlation
|
case no.
|
gender
|
age at diagnosis
|
studied
material
|
GTG-banding result
|
clinical symptoms
|
reference
|
21-
WU-seg/
/
1-1
|
-
|
-
|
-
|
-
|
-
|
-
|
mosaic cases
case no.
|
gender
|
age at
diagnosis
|
studied
material
|
GTG-banding
result
|
clinical
symptoms
|
reference
|
21-
WU-seg/
q21.1/
mos/
1-1
|
n.a.
|
29y
|
PBL
|
in aCGH,
dup(12)(p13.33p11.2) and del(21)(q22.2q22.3)
---
21q21.1 to
21qter
23.75 Mb [hg19]
40% mos
|
DD
|
{1363} case
35
|
|
mat
or pat UPD-cases with or unclear clinical
correlation + other imbalances |
case no.
|
gender
|
age at diagnosis
|
studied
material
|
GTG-banding result
|
clinical symptoms
|
reference
|
21-
WU-imb/
1-1
|
- |
- |
- |
- |
- |
- |
mosaic cases
case no.
|
gender
|
age at
diagnosis
|
studied
material
|
GTG-banding
result
|
clinical
symptoms
|
reference
|
21-
WU-imb/
mos/
1-1
|
n.a.
|
prenatal
|
fibroblasts
|
aCGH x3.4:
21q11.2-21q21.1
aCGH x1 (30%): 21q21.1-21qter
iUPD: 21q21.1-21qter
(70%) |
AMA; TOP
|
{1363} case
52
|
|
|
|